NCT01740609View on ClinicalTrials.gov

A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Healthy
Interventions
DRUG

Placebo

Placebo

BIOLOGICAL

PF-06342674 Dose A

Single SC Dose

BIOLOGICAL

PF-06342674 Dose B

Single SC Dose

BIOLOGICAL

PF-06342674 Dose C

Single SC Dose

BIOLOGICAL

PF-06342674 Dose D

Single SC Dose

BIOLOGICAL

PF-06342674 Dose E

Single SC Dose

BIOLOGICAL

PF-06342674 Dose F

Single IV Dose

BIOLOGICAL

PF-06342674 Dose G

Single SC Dose

BIOLOGICAL

PF-06342674 Dose H

Single IV Dose

BIOLOGICAL

PF-06342674 Dose I

Single SC Dose

BIOLOGICAL

PF-06342674 Dose J

Single IV Dose

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT01740609 - A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers | Biotech Hunter | Biotech Hunter